日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma.

多发性骨髓瘤中抗 GPRC5D CAR T 细胞疗法后 GPRC5D 丢失的遗传和表观遗传机制。

Ma Sha, Xia Jieyun, Zhang Miao, Li Wenyu, Xiao Meng, Sha Yuqian, Wang Wenya, Zhou Jianteng, Wang Ying, Qi Kunming, Fu Chunling, Sun Zengtian, Zhou Dian, Sun Qian, Qiu Tingting, Yan Zhiling, Zhu Feng, Chen Wei, Cheng Hai, Sang Wei, Cao Jiang, Li Depeng, Li Zhenyu, Fulciniti Mariateresa, Yao Yao, Xu Kailin, Niu Mingshan

Retraction Note: GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death

撤稿声明:GRP78 决定胶质母细胞瘤对 UBA1 抑制诱导的 UPR 信号通路和细胞死亡的敏感性

Liu, Guanzheng; Yu, Jiefeng; Wu, Runqiu; Shi, Lin; Zhang, Xu; Zhang, Wanhong; Zhong, Xiaomin; Wang, Yifeng; Li, Huan; Shen, Yang; Wu, Changyong; Yu, Rutong; Niu, Mingshan; Liu, Xuejiao

Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

撤稿声明:CRM1可逆抑制剂通过阻断NF-κB信号通路增强胶质母细胞瘤细胞对辐射的敏感性。

Liu, Xuejiao; Tu, Yiming; Wang, Yifeng; Zhou, Di; Chong, Yulong; Shi, Lin; Liu, Guanzheng; Zhang, Xu; Wu, Sijin; Li, Huan; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong

Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

粒细胞集落刺激因子与嵌合抗原受体T细胞疗法治疗复发或难治性B细胞急性淋巴细胞白血病的毒性和疗效之间的关联

Ma, Sha; Wang, Ying; Qi, Kunming; Lu, Wenyi; Qi, Yuekun; Cao, Jiang; Niu, Mingshan; Li, Depeng; Sang, Wei; Yan, Zhiling; Zhu, Feng; Cheng, Hai; Li, Zhenyu; Zhao, Mingfeng; Xu, Kailin

MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation

MALT1是胶质母细胞瘤的潜在治疗靶点,并在EGFR诱导的NF-κB激活中发挥关键作用。

Liu, Xuejiao; Yue, Chenglong; Shi, Lin; Liu, Guanzheng; Cao, Qiyu; Shan, Qianqian; Wang, Yifeng; Chen, Xiangyu; Li, Huan; Wang, Jie; Gao, Shangfeng; Niu, Mingshan; Yu, Rutong

High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia

miR-363高表达预示急性髓系白血病预后不良,并可指导治疗选择。

Zhang, Huihui; Zhang, Ninghan; Wang, Rong; Shao, Tingting; Feng, Yuan; Yao, Yao; Wu, Qingyun; Zhu, Shengyun; Cao, Jiang; Zhang, Huanxin; Li, Zhenyu; Liu, Xuejiao; Niu, Mingshan; Xu, Kailin

High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia

miR-25高表达预示急性髓系白血病患者化疗疗效良好

Niu, Mingshan; Feng, Yuan; Zhang, Ninghan; Shao, Tingting; Zhang, Huihui; Wang, Rong; Yao, Yao; Yao, Ruosi; Wu, Qingyun; Cao, Jiang; Liu, Xuejiao; Liu, Yubo; Xu, Kailin

Design of a liver cancer-specific selector for the analysis of circulating tumor DNA

设计一种肝癌特异性选择器用于循环肿瘤DNA分析

Sun, Yan; Meng, Rui; Tang, Heng; Wang, Huimin; Guo, Xueqin; Ma, Yuanyuan; Yang, Yun; Wei, Xiaoming; Mu, Feng; Wu, Gang; Wang, Jun; Liu, Jun; Niu, Mingshan; Xue, Jun

Advantages of digital PCR in the detection of low abundance BCR-ABL1 gene in patients with chronic myeloid leukemia

数字PCR在检测慢性粒细胞白血病患者低丰度BCR-ABL1基因方面的优势

Yan, Zhiling; Sun, Qian; Zhang, Huanxin; Han, Yahui; Qiao, Jianlin; Niu, Mingshan; Zhu, Shengyun; Zhao, Kai; Wu, Qingyun; Cheng, Hai; Cao, Jiang; Zeng, Lingyu; Li, Zhenyu; Xu, Kailin

MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy

急性髓系白血病中 miR-425 表达谱的分析可能有助于指导异基因移植和化疗之间的治疗选择。

Yang, Chen; Shao, Tingting; Zhang, Huihui; Zhang, Ninghan; Shi, Xiaoying; Liu, Xuejiao; Yao, Yao; Xu, Linyan; Zhu, Shengyun; Cao, Jiang; Cheng, Hai; Yan, Zhiling; Li, Zhenyu; Niu, Mingshan; Xu, Kailin